<p>The Indian Council of Medical Research (ICMR) is assisting an inquiry into an alleged adverse reaction during AstraZeneca's Covid-19 vaccine trial, but has found no reason to recommend halting it, a senior official at the regulator said on Sunday.</p>.<p>A 40-year-old man said in a complaint seen by Reuters that he had suffered serious "neurological and psychological" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII).</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/national/covishield-vaccine-trial-participant-alleges-neuro-breakdown-demands-rs-5-crore-compensation-from-serum-institute-921300.html" target="_blank">Covishield vaccine trial participant alleges neuro breakdown; demands Rs 5 crore compensation from Serum Institute</a></strong></p>.<p>"There was no immediate cause of concern at this stage," Samiran Panda, head of Epidemiology and Communicable Diseases at the ICMR, the research body involved in trials, told Reuters.</p>.<p>"It doesn't mean that long term assessment will not happen, it is still happening. I am aware of the activity," Panda said.</p>.<p>AstraZeneca did not respond to a request for comment.</p>.<p>Law firm N.G.R. Prasad & R. Rajaram Advocates sent the complaint by the unnamed volunteer, who is seeking 50 million rupees ($676,288) in compensation and a suspension of testing, manufacturing and distribution of the vaccine, to ICMR, SII, AstraZeneca and the Drugs Controller General of India.</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>"While the Serum Institute of India is sympathetic with the volunteer's medical condition, there's absolutely no correlation with the vaccine trial," SII said.</p>.<p>"(The) volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent," it added.</p>.<p>The Drugs Controller General of India, who is responsible for drug and vaccine approval, could not immediately be reached for comment on Sunday. </p>
<p>The Indian Council of Medical Research (ICMR) is assisting an inquiry into an alleged adverse reaction during AstraZeneca's Covid-19 vaccine trial, but has found no reason to recommend halting it, a senior official at the regulator said on Sunday.</p>.<p>A 40-year-old man said in a complaint seen by Reuters that he had suffered serious "neurological and psychological" symptoms after receiving the vaccine in a trial being run by the British drugmaker's partner Serum Institute of India (SII).</p>.<p><strong>Also read — <a href="https://www.deccanherald.com/national/covishield-vaccine-trial-participant-alleges-neuro-breakdown-demands-rs-5-crore-compensation-from-serum-institute-921300.html" target="_blank">Covishield vaccine trial participant alleges neuro breakdown; demands Rs 5 crore compensation from Serum Institute</a></strong></p>.<p>"There was no immediate cause of concern at this stage," Samiran Panda, head of Epidemiology and Communicable Diseases at the ICMR, the research body involved in trials, told Reuters.</p>.<p>"It doesn't mean that long term assessment will not happen, it is still happening. I am aware of the activity," Panda said.</p>.<p>AstraZeneca did not respond to a request for comment.</p>.<p>Law firm N.G.R. Prasad & R. Rajaram Advocates sent the complaint by the unnamed volunteer, who is seeking 50 million rupees ($676,288) in compensation and a suspension of testing, manufacturing and distribution of the vaccine, to ICMR, SII, AstraZeneca and the Drugs Controller General of India.</p>.<p><a href="https://www.deccanherald.com/science-and-environment/coronavirus-vaccine-live-updates-covaxin-clinical-trials-human-trials-coronavirus-vaccine%20tracker-india-russia-us-china-oxford-moderna-bharat-biotech-866148.html" target="_blank"><strong>Coronavirus vaccine news live updates on DH</strong></a></p>.<p>"While the Serum Institute of India is sympathetic with the volunteer's medical condition, there's absolutely no correlation with the vaccine trial," SII said.</p>.<p>"(The) volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent," it added.</p>.<p>The Drugs Controller General of India, who is responsible for drug and vaccine approval, could not immediately be reached for comment on Sunday. </p>